Gene · 8467
SMARCA5: SNF2 related chromatin remodeling ATPase 5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SMARCA5: SNF2 related chromatin remodeling ATPase 5. Genes, record 8467. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8467
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O60264 | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 | 1,052 | 15 | Ensembl, GeneID, HGNC |
Source UniProt
Patents21
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 65977 | O60264 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3192 | O60264 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2755 | O60264 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15634 | O60264 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2755 | O60264 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3192 | O60264 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15634 | O60264 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15634 | O60264 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15473 | O60264 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 85396 | O60264 | Espacenet |
1 to 10 of 21
See all 21 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,041
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SMARCA5 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 15 | 2025 |
| R35GM127020 | ATP-dependent and independent mechanisms of regulating chromatin states | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 4 | 2025 |
| R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 4 | 2025 |
| R01EY012200 | Pax6 as a key regulator of lens development | 4 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 3 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,041Source NIH's project files
See all 1,041 nih grantsPapers1,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction to: RSF-1/hSNF2H Promotes the Proliferation and Migration of Adenoid Cystic Cancer Cells. | Bull Exp Biol Med | 2026 | 42799980 | PubTator, text mining | PubMed |
| ISWI/CHRAC orchestrates sequential chromatin-remodeling activities by mobilizing DNA polymerase ε for homologous recombination. | Commun Biol | 2026 | 42744936 | PubTator, text mining | PubMed |
| Dysregulation of circ-SMARCA5, circ-RHOT1, and HNF1A and the association of HNF1A polymorphisms with hepatocellular carcinoma. | Mol Biol Rep | 2026 | 42663735 | PubTator, text mining | PubMed |
| Chromatin remodeling and epigenetic regulation of mesenchymal stem/stromal cells in osteoarthritis. | Front Genet | 2026 | 42626673 | PubTator, text mining | PubMed |
| GSDME acts as an epigenetic modifier to promote melanoma development via centriole biogenesis regulator PLK4. | Cell Death Differ | 2026 | 42185629 | PubTator, text mining | PubMed |
| Gasdermin C reprograms metabolism through the CAMKK2-AMPK axis to promote lung adenocarcinoma progression and radioresistance. | Cell Rep | 2026 | 42176271 | PubTator, text mining | PubMed |
| Correction to the article "RSF-1/hSNF2H Promotes the Proliferation and Migration of Adenoid Cystic Cancer Cells". | Bull Exp Biol Med | 2026 | 42120794 | PubTator, text mining | PubMed |
| RETRACTION: Circular RNA SMARCA5 May Serve as a Tumor Suppressor in Non-Small Cell Lung Cancer. | J Clin Lab Anal | 2026 | 41972935 | PubTator, text mining | PubMed |
| RSF-1/hSNF2H Promotes the Proliferation and Migration of Adenoid Cystic Cancer Cells. | Bull Exp Biol Med | 2026 | 41949721 | PubTator, text mining | PubMed |
| Vector semantics of multidomain protein architectures. | Bioinform Adv | 2026 | 41938593 | PubTator, text mining | PubMed |
1 to 10 of 1,650
See all 1,650 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8467
GET https://conductscience.org/api/genes/v1/8467/patents?page=2